Early trial tests new weapon against tough cancers
NCT ID NCT02937272
Summary
This early-stage study is testing the safety of an experimental drug called LY3200882 in people with advanced solid tumors. Researchers are enrolling 223 participants to determine the highest dose that can be given safely and to look for initial signs that the drug might help control cancer. The study focuses on monitoring side effects and how the body processes the medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHRU de Lille
Lille, 59037, France
-
Calvary Mater Newcastle
Newcastle, New South Wales, 2298, Australia
-
Charité Campus Virchow-Klinikum
Berlin, 12203, Germany
-
Greenslopes Private Hospital
Greenslopes, Queensland, 4120, Australia
-
Gustave Roussy
Villejuif, 94805, France
-
Hopital Saint-Louis
Paris, Cedex 10, 75475, France
-
Hospital Clínico Universitario de Valencia
Valencia, 46010, Spain
-
Hospital Universitari Vall d'Hebron
Barcelona, 08035, Spain
-
Hospital Universitario 12 de Octubre
Madrid, 28041, Spain
-
Istituto Clinico Humanitas
Rozzano, Milano, 20089, Italy
-
National Cancer Center Hospital
Chuo-Ku, Tokyo, 104-0045, Japan
-
Ospedale Policlinico Giambattista Rossi, Borgo Roma
Verona, 37134, Italy
-
Princess Margaret Hospital (Ontario)
Lai Chi Kok, Kowloon, Canada
-
St Vincent's Hospital Sydney
Sydney, New South Wales, 2010, Australia
-
University of Louisville
Louisville, Kentucky, 40202, United States
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Universitätsklinikum Würzburg A. ö. R.
Würzburg, Bavaria, 97080, Germany
-
Weill Cornell Medical College
New York, New York, 10021, United States
Conditions
Explore the condition pages connected to this study.